Nineteen genes (44%) demonstrated loss or promoter silencing of the wildtype allele in at least one tumour, with six genes (SLC12A4, LOXL2, ZCCHC4, LLGL2, MIPOL1, SCYL3) demonstrating this in multiple samples (Fig. 1). This evidence concerns the gene LOXL2 and neoplasm.